Prudo-Chlebosz Raymond → Akari Therapeutics Plc AKTX

Stake: 9.30% Shares: 4,926,600,800 CUSIP: 00972G207 Class: Ordinary Shares, $0.0001 par value

Item 4 — Purpose of Transaction

On December 2, 2024, Dr. Prudo purchased the securities described in the November 2024 Private Placement as described in Item 3 above.

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 1.00

5,810 shares short · -96.6% vs prior

Filed	Form	Filer	Stake	Shares
2021-10-18	SC	RPC Pharma Ltd	—	—	view →

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.